Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Neoplasms
29
Tumors
26
Cancer
15
Oncology
11
44.81 neoplasms, tumors
9
Oncologie
6
therapy
6
Kanker
4
Biomarkers, Tumor
3
Medical Oncology
3
Zeitschrift
3
Antineoplastic Agents
2
Antineoplastic agents
2
Carcinogenese
2
Chemotherapy
2
Immunological aspects
2
Immunotherapy
2
Onkologie
2
Pe ́riodiques
2
Research
2
Surgery
2
Treatment
2
Tumeurs
2
Tumors in children
2
genetics
2
surgery
2
ACCIDENTES
1
ALERGIAS
1
Adolescent
1
Alimentation
1
-
11141por Shengzhe Zhang, Meiying Zhang, Ying Jing, Xia Yin, Pengfei Ma, Zhenfeng Zhang, Xiaojie Wang, Wen Di, Guanglei Zhuang“... inhibition sensitises tumor cells to BH3 mimetic inhibitors....”
Publicado 2018
Enlace del recurso
article -
11142por Yusuke Shiozawa, Luca Malcovati, Anna Gallì, Aiko Sato-Otsubo, Keisuke Kataoka, Yusuke Sato, Yosaku Watatani, Hiromichi Suzuki, Tetsuichi Yoshizato, Kenichi Yoshida, Masashi Sanada, Hideki Makishima, Yuichi Shiraishi, Kenichi Chiba, Eva Hellström-Lindberg, Satoru Miyano, Seishi Ogawa, Mario Cazzola“... describe splicing factor gene mutations in myelodysplasia and report tumor suppressor, epigenetic, iron...”
Publicado 2018
Enlace del recurso
article -
11143por Loukia G. Karacosta, Benedict Anchang, Nikolaos Ignatiadis, Samuel C. Kimmey, Jalen A. Benson, Joseph B. Shrager, Robert Tibshirani, Sean C. Bendall, Sylvia K. Plevritis“...Intermediate transitions between epithelial and mesenchymal states are associated with tumor...”
Publicado 2019
Enlace del recurso
article -
11144por Helen R. Davies, Kirsty Hodgson, Edward Schwalbe, Jonathan Coxhead, Naomi Sinclair, Xueqing Zou, Simon Cockell, Akhtar Husain, Serena Nik-Zainal, Neil Rajan“... mutations in the tumor suppressor CYLD. Here, the authors highlight recurrent mutations in DNMT3A and BCOR...”
Publicado 2019
Enlace del recurso
article -
11145por Yimeng Ren, Yun Qian, Luoyan Ai, Yile Xie, Yaqi Gao, Ziyan Zhuang, Jinxian Chen, Ying-Xuan Chen, Jing-Yuan Fang“...-mediated recycling of PD-L1, affecting T-cell-mediated anti-tumor immune responses....”
Publicado 2021
Enlace del recurso
article -
11146Hepatocarcinoma, porfiria y hemosiderosis. Una asociación no reportada en nuestro país: Caso clínico“... carcinoma. We report a 69-year-old man with PTC, hemosiderosis and hepatocarcinoma. The tumor was diagnosed...”
Enlace del recurso
-
11147“... of the tumor as the main determinant of patient survival and response to treatment. There is an association...”
Enlace del recurso
-
11148por Mila,Rafael, Grille,Sofía, Laurini,Marcelo, Lapiedra,Diego, Bagattini,Juan Carlos“...Villous colorectal adenomas are common tumors that normally provoke scarce symptomatology. We...”
Publicado 2008
Enlace del recurso
-
11149“... fractures. The patient had a 4-cm parathyroid tumor, that was surgically excised, along with the ipsilateral...”
Enlace del recurso
-
11150por Gallardo E,Jorge, Cabrera A,Elsa, Rubio L,Betzabé, González V,Carolina, Cortés A,Claudio“... in patients with inoperable tumors ranges between 5 and 8 months. There are few studies on the effects...”
Publicado 2001
Enlace del recurso
-
11151por Navarrete-Dechent,Cristián, Molgó,Montserrat, Sandoval-Osses,Mauricio, González,Sergio“...-positive lymphoproliferative disorders. It presents as localized or multifocal tumors or plaques...”
Publicado 2015
Enlace del recurso
-
11152por Avila,Rodolfo Esteban, Samar,María Elena, Fonseca,Ismael Bernardo, Corball,Alberto Gustavo, Carriel,Víctor, García-Martinez,Laura, Rodríguez,Ismael“... oncocíticos. Los tumores oncocíticos constituyen el 1 % de todos los tumores salivales y entre el 82 y 90 % se...”
Publicado 2019
Enlace del recurso
-
11153por Domínguez E,Miguel, Torres O,José, Pérez P,Gilberto, Volpato V,Roberto, Jadresic V,Alfredo, López C,Enrique“..., histología, grado de diferenciación, extensión anatómica del tumor, la presencia de metástasis linfáticas y a...”
Publicado 2011
Enlace del recurso
-
11154“...RESUMEN Introducción: El fibroangioma nasofaríngeo juvenil es un tumor vascular benigno localmente...”
Enlace del recurso
-
11155por Katsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, Koji Tsuta, Mitsugu Sekimoto, Tomoharu Sugie“... (companion diagnostic for atezolizumab), and E1L3N assays. PD-L1 expression on immune cells (ICs) and tumor...”
Publicado 2021
Enlace del recurso
article -
11156“... in immunocompromised mice, tumors from HV1 KO cells grew less than WT in mass, with lower staining for the Ki-67 marker...”
Enlace del recurso
article -
11157por Ivaylo B Mihaylov, Tulasigeri M Totiger, Teresa M Giret, Dazhi Wang, Benjamin Spieler, Scott Welford“... were used: four as control and the rest were subjected to combined RT plus IT regimen. Tumors were...”
Publicado 2021
Enlace del recurso
article -
11158por Tairine Zara-Lopes, Ana Lívia Silva Galbiatti-Dias, Márcia Maria Urbanin Castanhole-Nunes, João Armando Padovani-Júnior, José Victor Maniglia, Erika Cristina Pavarino, Eny Maria Goloni-Bertollo“... consumption (OR = 1.97, 95% CI: 1.28–3.04, p G polymorphism showed an association with tumor extent...”
Publicado 2019
Enlace del recurso
article -
11159por Scott G. Daniel, Corbie L. Ball, David G. Besselsen, Tom Doetschman, Bonnie L. Hurwitz“... production from Lachnospiraceae bacterium A4, which could promote tumor formation. H. hepaticus causes...”
Publicado 2017
Enlace del recurso
article -
11160por Jennifer L Davis, Roman Thaler, Linda Cox, Biancamaria Ricci, Heather M Zannit, Fei Wan, Roberta Faccio, Amel Dudakovic, Andre J van Wijnen, Deborah J Veis“...Aberrant NF-κB signaling fuels tumor growth in multiple human cancer types including both...”
Publicado 2021
Enlace del recurso
article